Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
Add more filters










Publication year range
1.
Am J Physiol Endocrinol Metab ; 308(2): E111-21, 2015 Jan 15.
Article in English | MEDLINE | ID: mdl-25389365

ABSTRACT

The aim of the present work was to determine the effects of liver growth factor (LGF) on the regeneration process of rat testes after chemical castration induced by ethane dimethanesulfonate (EDS) by analyzing some of the most relevant proteins involved in cholesterol metabolism, such as hormone sensitive lipase (HSL), 3ß-hydroxysteroid dehydrogenase (3ß-HSD), scavenger receptor SR-BI, and other components of the SR family that could contribute to the recovery of steroidogenesis and spermatogenesis in the testis. Sixty male rats were randomized to nontreated (controls) and LGF-treated, EDS-treated, and EDS + LGF-treated groups. Testes were obtained on days 10 (T1), 21 (T2), and 35 (T3) after EDS treatment, embedded in paraffin, and analyzed by immunohistochemistry and Western blot. LGF improved the recovery of the seminiferous epithelia, the appearance of the mature pattern of Leydig cell interstitial distribution, and the expression of mature SR-BI. Moreover, LGF treatment resulted in partial recovery of HSL expression in Leydig cells and spermatogonia. No changes in serum testosterone were observed in control or LGF-treated rats, but in EDS-castrated animals LGF treatment induced a progressive increase in serum testosterone levels and 3ß-HSD expression. Based on the pivotal role of SR-BI in the uptake of cholesteryl esters from HDL, it is suggested that the observed effects of LGF would facilitate the provision of cholesterol for sperm cell growth and Leydig cell recovery.


Subject(s)
Bilirubin/pharmacology , CD36 Antigens/metabolism , Leydig Cells/metabolism , Serum Albumin/pharmacology , Spermatogenesis/physiology , Sterol Esterase/metabolism , Testis/metabolism , Animals , Blotting, Western , Immunohistochemistry , Male , Mesylates/administration & dosage , Random Allocation , Rats , Rats, Wistar , Serum Albumin, Human , Sperm Motility , Testis/cytology , Testosterone/blood
2.
J Diabetes Res ; 2013: 254529, 2013.
Article in English | MEDLINE | ID: mdl-23984430

ABSTRACT

The role of diabetic nephropathy in the outcome of acute renal injury (AKI) is not well defined. Herein we evaluate the outcome of lipopolysaccharide- (LPS-) induced AKI in streptozotocin-induced diabetes, as well as the potential role of Hypoxia Inducible Factor (HIF-1 α ) in this condition. Although 6 h after LPS injection all mice developed a decrease in renal function, proteinuric diabetic mice showed a better recovery of this parameter throughout the study (72 h). Both HIF-1 α and vascular endothelium growth factor (VEGF) were found to be upregulated in diabetic mice. After LPS injection, all animals showed an upregulation of these factors, although it was higher in the diabetic group. Glycated albumin (GA) was found to upregulate HIF-1 α in HK-2 cells, which resulted in increased production of VEGF. Interestingly, LPS cooperated with GA to induce HIF-1 α upregulation. In conclusion, diabetic mice display a better recovery of AKI after experimental endotoxemia. Moreover, these animals showed an increased expression of both HIF-1 α and VEGF that was reproduced by incubating renal cells with GA. Since VEGF is considered a survival factor for tubular cells, our findings suggest that diabetes displays HIF-1 α upregulation that might function as a "precondition state" offering protection from endotoxic AKI.


Subject(s)
Acute Kidney Injury/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetic Nephropathies/metabolism , Endotoxemia/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Kidney/metabolism , Acute Kidney Injury/complications , Acute Kidney Injury/genetics , Animals , Cell Line , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/genetics , Diabetic Nephropathies/complications , Diabetic Nephropathies/genetics , Endotoxemia/complications , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Mice , Up-Regulation , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
3.
Ann Oncol ; 17(1): 60-4, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16282247

ABSTRACT

BACKGROUND: The involvement of thyroid hormones in the development and differentiation of normal breast tissue has been established. However, the association between breast cancer and these hormones is controversial. Therefore, the objective of the present study was to determine the protein expression pattern of thyroid hormone receptors in different human breast pathologies and to evaluate their possible relationship with cellular proliferation. PATIENTS AND METHODS: The presence of thyroid hormone receptors was evaluated by immunohistochemistry and western blot analysis in 84 breast samples that included 12 cases of benign proliferative diseases, 20 carcinomas in situ and 52 infiltrative carcinomas. RESULTS: TR-alpha was detected in the nuclei of epithelial cells from normal breast ducts and acini, while in any pathological type this receptor was located in the cytoplasm. However, TR-beta presented a nuclear location in benign proliferative diseases and carcinomas in situ and a cytoplasmatic location in normal breast and infiltrative carcinomas. The highest proliferation index was observed in carcinomas in situ, although in infiltrative carcinomas an inverse correlation between this index and the TR-alpha expression was encountered. CONCLUSIONS: The results of this study reveal substantial changes in the expression profile of thyroid hormone receptors suggesting a possible deregulation that could trigger breast cancer development.


Subject(s)
Breast Diseases/metabolism , Breast Neoplasms/metabolism , Cell Proliferation , Receptors, Thyroid Hormone/metabolism , Blotting, Western , Breast/metabolism , Breast Diseases/pathology , Breast Neoplasms/pathology , Carcinoma in Situ/metabolism , Carcinoma in Situ/pathology , Carcinoma, Ductal, Breast/metabolism , Carcinoma, Ductal, Breast/pathology , Carcinoma, Lobular/metabolism , Carcinoma, Lobular/pathology , Disease Progression , Female , Fibroadenoma/metabolism , Fibroadenoma/pathology , Humans , Immunohistochemistry
4.
Int J Oncol ; 25(4): 1183-91, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15375571

ABSTRACT

Vitamin D3 (VD) and all-trans-retinoic acid (ATRA) have been postulated as a novel treatment option for breast carcinoma. Since the combined effects of retinoids and VD derivatives are attributed to heterodimeric interactions between members of the nuclear receptor family, the expression patterns of the heterodimers formed by vitamin D3 receptor (VDR) and the retinoid receptors RARs (RAR-alpha, RAR-beta and RAR-gamma) and RXRs (RXR-alpha, RXR-beta and RXR-gamma) have been studied by immunohistochemistry in benign and malignant breast tissues. Present results revealed that immunoexpressions to all receptor types studied were higher in both in situ and infiltrative carcinomas than in benign breast diseases. In a variable number of cases of infiltrative carcinoma, immunostaining appeared in the nucleus, whereas in the other two disorders immunostaining was only cytoplasmic. The correlation established between VDR and the different isoforms of retinoid receptors revealed that VDR seems to select mainly RAR-alpha to form heterodimers and to exert their properties as transcription factor. The results of this study suggest that this heterodimer plays a critical role in cancer malignancy, and its presence indicates those patient groups presenting a better response to adjuvant therapies based on the combination of vitamin D and ATRA.


Subject(s)
Breast Neoplasms/chemistry , Receptors, Calcitriol/analysis , Receptors, Retinoic Acid/analysis , Retinoid X Receptors/analysis , Adult , Aged , Blotting, Western , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Dimerization , Female , Humans , Middle Aged , Receptors, Calcitriol/chemistry , Receptors, Retinoic Acid/chemistry , Retinoid X Receptors/chemistry , Tretinoin/administration & dosage , Vitamin D/administration & dosage
12.
Mol Reprod Dev ; 62(2): 216-22, 2002 Jun.
Article in English | MEDLINE | ID: mdl-11984832

ABSTRACT

Retinoid acid receptors (RXR-alpha, -beta, -gamma) and Farnesoid X-activated receptor (FXR) expression in the testis of the marbled newt were investigated with special attention to the changes during the annual testicular cycle, using light microscopy immunohistochemistry and Western blot analysis. The annual testicular cycle of the marbled newt (Triturus marmoratus marmoratus) comprises three periods: (a) proliferative period (germ cell proliferation from primordial germ cells to round spermatids, April-June); (b) spermiogenesis period (July-September); and (c) quiescence period (interstitial and follicular cells form the glandular tissue, October-April). In the proliferative period, primordial germ cells and primary spermatogonia immunostained intensely to the three types of RXRs and also to FXR. In the other periods, immunostaining to these antibodies was weak or absent. Secondary spermatogonia stained weakly to the four antibodies in the proliferative period, and only to FXR, also weakly, in the spermiogenesis period. Immunoreactive primary spermatocytes were weakly labeled with the RXR antibodies in the proliferative period. Spermatids and spermatozoa did not stain to any antibody in any period. Follicular cells only immunostained to RXR-gamma and only in the quiescence period when they are forming the glandular tissue, together with the interstitial cells. As follicular cells, interstitial cells only immunostained in the quiescence period; however, they immunoreacted to the three types of RXRs. These findings suggest that in the newt, RXRs and FXR are involved in spermatogenesis control by regulating the proliferation of primordial germ cells and spermatogonia. In addition, RXR-gamma seems to be also involved in the development of the glandular (steroidogenic) tissue.


Subject(s)
DNA-Binding Proteins/analysis , Receptors, Cytoplasmic and Nuclear/analysis , Receptors, Retinoic Acid/analysis , Testis/chemistry , Transcription Factors/analysis , Animals , Blotting, Western/methods , Immunoenzyme Techniques , Male , Retinoid X Receptors , Salamandridae
13.
J Anat ; 199(Pt 4): 465-72, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11693307

ABSTRACT

Expression of androgen receptor (AR), estrogen receptor alpha (ER-alpha) and estrogen receptor beta (ER-beta) in the testis of the marbled newt (Triturus marmoratus marmoratus) was investigated, with special attention to changes during the annual testicular cycle, using light microscopy immunohistochemistry and Western blot analysis. Primordial germ cells, primary and secondary spermatogonia and spermatocytes showed a positive reaction to the 3 receptor antibodies during the annual reproductive cycle. Follicular cells were positive to AR, ER-alpha and ER-beta during the spermiogenesis and quiescence periods in the glandular tissue. Interstitial cells showed reactivity to AR, ER-alpha and ER-beta in the spermiogenesis and the quiescence periods, and presented no labelling to these receptors in the proliferative period. These findings suggest that, as in mammals, there is an androgen-estrogen regulation of the function and development of the newt testis.


Subject(s)
Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism , Spermatozoa/metabolism , Testis/metabolism , Triturus/metabolism , Animals , Blotting, Western/methods , Estrogen Receptor alpha , Estrogen Receptor beta , Immunohistochemistry/methods , Male , Receptors, Androgen/analysis , Receptors, Estrogen/analysis , Spermatocytes/chemistry , Spermatocytes/metabolism , Spermatogenesis/physiology , Spermatogonia/chemistry , Spermatogonia/metabolism , Spermatozoa/chemistry , Testis/chemistry
15.
J Endocrinol ; 168(3): 447-54, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11241176

ABSTRACT

Two different estrogen receptors (ER-alpha and ER-beta) have been described, which are differentially involved in regulating the normal function of reproductive tissues. ER-alpha was considered for a long time to be the only estrogen receptor, and it has been detected in the stromal cells of the human prostate but not in the epithelium. To obtain new information about the differential effects of both receptor types, we have investigated their localization in normal prostates, benign prostatic hyperplasia (BPH), and prostatic cancer (PC) by immunohistochemistry, ELISA and Western blot. Epithelial immunostaining was absent in normal prostates and was present in BPH (10% of cells) and PC (80% of cells), whereas about 15% of stromal cells were positively immunostained for ER-alpha in the three types of prostatic specimens studied. Epithelial immunostaining for ER-beta was detected in normal prostates (13% of cells), BPH (30% of cells) and PC (79% of cells), whereas stromal immunostaining for ER-beta was absent in normal and hyperplastic prostates and was present in PC (12% of cells). The complementary presence of both receptor types in the normal prostate (ER-beta in the epithelium and ER-alpha in the stroma) might explain the mechanism of estrogen action in the development of BPH. The increased epithelial immunostaining for both ER-alpha and ER-beta in BPH and PC suggests that the involvement of estrogen receptors in hyperplasia and cancer concerns mainly the epithelium.


Subject(s)
Neoplasm Proteins/metabolism , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism , Receptors, Estrogen/metabolism , Adult , Aged , Aged, 80 and over , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Estrogen Receptor alpha , Estrogen Receptor beta , Humans , Immunoenzyme Techniques , Male , Middle Aged , Prostate/metabolism
16.
J Androl ; 22(1): 79-87, 2001.
Article in English | MEDLINE | ID: mdl-11191091

ABSTRACT

The main oligosaccharide residues and the saccharide linkage in infantile and adult human seminal vesicles were studied by means of lectin histochemistry at light and electron microscopy levels. In adult glands, the epithelial cell cytoplasm and luminal content reacted positively to the following residues: (GlcNAc)n (WGA), Galbeta1,3GalNAc (PNA), GalNAcalpha1,3Gal (SBA), GalNAcalpha1,3GalNAc (HPA), Fucalpha1,2Galbeta1,4GlcNAc (UEA-I), and alphaL-Fuc1,6DGlcNAc-O-Melibiosc (AAA). The presence of intense staining in the luminal content suggest that glycoproteins containing these oligosaccharide moieties are secreted by epithelial cells. Adult epithelial cells also reacted to Neu5Acalpha2,6Gal (SNA), Neu5Acalphaa2,3Galbeta1,4GlcNAc (MAA), Galbeta1,4GlcNAc (DSA), branched mannose chains (ConA), Man1,3Man (GNA), and Fucalpha1,2Galbeta1,4GlcNAcFucalpha1,3GlcNAc (LTA) but reaction to these residues was weak (MAA, DSA, ConA, and LTA) or absent (SNA and GNA) in the gland lumen, which suggests that they belong to intracytoplasmic proteins. The chemical and enzymatic treatments used suggest that the residues recognized by SNA, MAA, PNA, DSA, HPA, and SBA belong to O-linked oligosaccharides; those residues localized by ConA and GNA have an N-glycosidic linkage, and those bound by WGA, LTA, UEA-I, and AAA are linked to both N- and O-oligosaccharides. In prepubertal seminal vesicles, reaction in the epithelial cell cytoplasm was similar to that observed in adults, except for GNA and HPA, which showed a weaker reaction. However, the lumen of prepubertal seminal vesicles showed intense reaction to WGA and SBA only. The chemical and enzymatic treatments suggest that the scanty glycoproteins secreted by the prepubertal glands belong to the mucin-type.


Subject(s)
Oligosaccharides/analysis , Seminal Vesicles/chemistry , Seminiferous Epithelium/chemistry , Adult , Age Factors , Humans , Infant , Lectins , Male , Microscopy, Electron , Seminal Vesicles/ultrastructure , Seminiferous Epithelium/ultrastructure
17.
Int J Androl ; 24(1): 37-47, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11168649

ABSTRACT

In order to clarify the ageing-related histological changes in the human prostate, a quantitative morphometric analysis was performed. Complete prostates were obtained at autopsy from 281 men (aged 20-84 years) who died in traffic accidents and presented no clinical symptoms of prostatic disease. The prostates were classified as: histologically normal (n=182), with nodular hyperplasia (n=42), with intraepithelial neoplasia (n=40) and carcinomatous with low Gleason grade (n=20). Each prostate was divided into three regions (periurethral, central and peripheral) and the volume of each region, as well as the average volume occupied by stroma and epithelium in each region were quantified. For each parameter, the average values for each age group were compared. In the histologically normal prostates, an increase with ageing in the total volume and the volume occupied by the central region were observed; these increases were mainly caused by an increase in the stromal volume of the central region in men after 30 years of age. No histologically normal prostates were found in men older than 70 years of age. Nodular prostatic hyperplasia was found in men over 30 years of age and a fluctuation in the total volume throughout ageing was observed. Prostates with intraepithelial neoplasia (PIN) and carcinoma were observed in men aged >20 years and the total volume and those of each prostatic region showed multiple variations, except for the eighth decade where a marked increase with regard to that of the previous decades was observed.


Subject(s)
Prostate/anatomy & histology , Adult , Aged , Aged, 80 and over , Aging/physiology , Anthropometry , Humans , Male , Middle Aged , Prostate/pathology , Prostatic Hyperplasia/pathology , Reference Values
18.
Eur Cytokine Netw ; 12(4): 654-63, 2001.
Article in English | MEDLINE | ID: mdl-11781193

ABSTRACT

A comparative study of the expression of p21, Rb, mcl-1, and bad gene products, which are involved in the control of the cell cycle, was performed in normal, hyperplastic, and carcinomatous human prostates by means of a semiquantitative immunochemical study. This included Western blot, ELISA, and immunohistochemistry procedures. In normal prostates, immunoexpression of the four gene products was scanty or absent. In men with benign prostatic hyperplasia, immunoreactions to the four proteins studied were found in many epithelial cells and some stromal cells. In prostatic carcinoma, the immunostaining pattern was as in hyperplastic prostates but the numbers of both epithelial and stromal cells were higher. Present results indicate that immunoexpression of p21, Rb (both the phosphorylated and dephosphorylated forms), mcl-1, and bad gene products are markedly increased in prostates with proliferative alterations but that these proteins do not discriminate between benignant (hyperplasia) and malignant (adenocarcinoma) prostatic tumours, although immunoexpression is higher in prostatic carcinoma.


Subject(s)
Carrier Proteins/metabolism , Cyclins/metabolism , Neoplasm Proteins/metabolism , Prostate/metabolism , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/metabolism , Retinoblastoma Protein/metabolism , Adult , Aged , Blotting, Western , Cyclin-Dependent Kinase Inhibitor p21 , Enzyme-Linked Immunosorbent Assay , Humans , Male , Middle Aged , Myeloid Cell Leukemia Sequence 1 Protein , Proto-Oncogene Proteins c-bcl-2/metabolism , bcl-Associated Death Protein
20.
Emergencias (St. Vicenç dels Horts) ; 12(6): 418-423, dic. 2000. tab
Article in Es | IBECS | ID: ibc-058427

ABSTRACT

La política sanitaria actual tiende a la reducción de costes. En función de la presión asistencial se asignan los recursos y esto tiene una gran importancia en las denominadas “camas de críticos”, fundamentalmente las de las Unidades de Cuidados Intensivos (UCI), consideradas en general como “costosas”. Alternativas a las UCIs son aquellas unidades con monitorización suficiente para satisfacer las necesidades del paciente, fundamentalmente de aquellos que requieren procedimientos de diagnóstico y manejo de enfermería, pero no un cuidado médico estricto con el consiguiente ahorro económico. La presente revisión tiene como objeto la valoración de distintos puntos en relación a estas unidades, conviniendo en su posible utilidad en hospitales de segundo nivel o comarcales (AU)


Current health care policy shows a definite trend toward cost reduction. Resources are assigned in the light of assistential pressure, and this has a considerable impact on the socalled “critical patients beds”, mainly those in Intensive Care Units (ICU´s), which are generally considered to be “expensive”. An alternative to ICU´s might be the establishment of units with monitoring capabilities sufficient for satisfying the patients needs and requirements, mainly in those patients requiring diagnostic procedures and nursing management but not a strict medical care, with the corresponding econocmic savings. The present review has the aim to assess a number of aspect in relation to such units, stressing their possible usefulness in second-level or district hospitals (AU)


Subject(s)
Critical Care/methods , Critical Care/trends , Critical Care , Cost Allocation , Cost Control/methods , Health Care Costs/standards , Intermediate Care Facilities/methods , Intermediate Care Facilities/supply & distribution , Health Policy/trends , Organizational Policy
SELECTION OF CITATIONS
SEARCH DETAIL
...